USP3 inhibitors belong to a distinct chemical class designed to selectively target and modulate the activity of ubiquitin-specific protease 3 (USP3), a deubiquitinase enzyme involved in the regulation of various cellular processes. The chemical structure of USP3 inhibitors is characterized by specific molecular motifs that enable interaction with the catalytic site of USP3, thereby impeding its deubiquitinating activity. These small molecules typically exhibit a defined three-dimensional configuration that allows them to bind to key residues within the active site of USP3, disrupting the enzyme's ability to cleave ubiquitin moieties from substrate proteins.
Structurally, USP3 inhibitors often feature aromatic rings, heterocyclic compounds, and functional groups with hydrogen-bonding potential, contributing to their binding specificity. The chemical design of these inhibitors is based on a thorough understanding of the enzyme's structural biology and the identification of critical residues involved in substrate recognition and catalysis. Researchers employ various strategies, such as high-throughput screening and structure-activity relationship studies, to optimize the potency and selectivity of USP3 inhibitors. The goal is to fine-tune the chemical structure of these inhibitors to achieve maximal binding affinity and efficacy in disrupting USP3-mediated deubiquitination processes. As our understanding of the structural nuances of USP3 advances, so does the refinement of these inhibitors, paving the way for targeted interventions in cellular pathways where USP3 plays a regulatory role. The development of this chemical class contributes significantly to unraveling the intricate web of ubiquitin-mediated signaling within cells and holds promise for future investigations into the functional consequences of modulating USP3 activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
P22077 | 1247819-59-5 | sc-478536 | 10 mg | $165.00 | ||
This compound was identified as a selective inhibitor of USP7, but it also exhibited activity against USP3. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
IU1 is a small molecule inhibitor that was originally developed as a selective inhibitor of USP14, but it has also been reported to inhibit USP3. | ||||||
P005091 | 882257-11-6 | sc-478535 | 10 mg | $155.00 | ||
This compound has been studied for its inhibitory activity against several deubiquitinases, including USP3. | ||||||
WP1130 | 856243-80-6 | sc-364650 sc-364650A | 10 mg 50 mg | $490.00 $1484.00 | 1 | |
Although initially recognized as an inhibitor of USP9x, WP1130 has shown inhibitory effects against various deubiquitinases, including USP3. | ||||||
UCH-L3 Inhibitor | 30675-13-9 | sc-204370 | 10 mg | $156.00 | 1 | |
TCID (UCH-L3 Inhibitor) is a selective USP3 inhibitor that has been investigated in the context of its potential anti-cancer effects. | ||||||